# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-022334
Filing Date
2020-08-14
Accepted
2020-08-14 17:16:18
Documents
50
Period of Report
2020-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0620_actiniumpharma.htm | 10-Q | 590175
2 | AMENDMENT TO WARRANT TO PURCHASE COMMON STOCK OF ACTINIUM PHARMACEUTICALS, INC., | f10q0620ex10-2_actinium.htm | EX-10.2 | 12485
3 | EMPLOYMENT AGREEMENT, DATED AUGUST 12, 2020, BY AND BETWEEN ACTINIUM PHARMACEUTI | f10q0620ex10-3_actinium.htm | EX-10.3 | 63209
4 | EMPLOYMENT AGREEMENT, DATED AUGUST 12, 2020, BY AND BETWEEN ACTINIUM PHARMACEUTI | f10q0620ex10-4_actinium.htm | EX-10.4 | 64226
5 | EMPLOYMENT AGREEMENT, DATED AUGUST 12, 2020, BY AND BETWEEN ACTINIUM PHARMACEUTI | f10q0620ex10-5_actinium.htm | EX-10.5 | 50881
6 | EMPLOYMENT AGREEMENT, DATED AUGUST 12, 2020, BY AND BETWEEN ACTINIUM PHARMACEUTI | f10q0620ex10-6_actinium.htm | EX-10.6 | 60068
7 | CERTIFICATION | f10q0620ex31-1_actinium.htm | EX-31.1 | 13310
8 | CERTIFICATION | f10q0620ex31-2_actinium.htm | EX-31.2 | 11866
9 | CERTIFICATION | f10q0620ex32-1_actinium.htm | EX-32.1 | 6201
10 | CERTIFICATION | f10q0620ex32-2_actinium.htm | EX-32.2 | 6468
11 | GRAPHIC | ex10-3_001.jpg | GRAPHIC | 46607
12 | GRAPHIC | ex10-4_001.jpg | GRAPHIC | 23632
13 | GRAPHIC | ex10-5_001.jpg | GRAPHIC | 46571
14 | GRAPHIC | ex10-6_001.jpg | GRAPHIC | 46768
| Complete submission text file | 0001213900-20-022334.txt |  | 2938426

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
15 | XBRL INSTANCE FILE | atnm-20200630.xml | EX-101.INS | 337573
16 | XBRL SCHEMA FILE | atnm-20200630.xsd | EX-101.SCH | 35907
17 | XBRL CALCULATION FILE | atnm-20200630_cal.xml | EX-101.CAL | 34652
18 | XBRL DEFINITION FILE | atnm-20200630_def.xml | EX-101.DEF | 92074
19 | XBRL LABEL FILE | atnm-20200630_lab.xml | EX-101.LAB | 230955
20 | XBRL PRESENTATION FILE | atnm-20200630_pre.xml | EX-101.PRE | 162636

Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 201106585
SIC: 2834 Pharmaceutical Preparations